Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 5/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 5/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 5/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CHKA | P35790 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.32 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.32 |
| ▸ | HRH2 | P25021 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8581907 | 0.98 | GNAI3 (0.40) | GNAI3GNAO1GNAI1CA2CA12 | |
| SCHEMBL5875102 | 0.98 | GNAI3 (0.40) | GNAI3GNAO1GNAI1CA2CA12 | |
| SCHEMBL5875158 | 0.96 | TSHR (0.34) | GNAI3GNAO1GNAI1CA2CA12 | |
| SCHEMBL28251269 | 0.93 | ITGB3 (0.41) | GNAI3GNAO1GNAI1ITGB3ITGA2B | |
| SCHEMBL5008157 | 0.91 | CA2 (0.37) | GNAI3GNAO1GNAI1CA2CA12 | |
| SCHEMBL5874316 | 0.91 | GNAI3 (0.50) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL27888271 | 0.90 | CAMK2A (0.32) | GNAI3GNAO1GNAI1CA2CA12 | |
| SCHEMBL5874398 | 0.89 | GNAI3 (0.53) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL5875251 | 0.89 | GNAI3 (0.53) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL5874232 | 0.89 | GNAI3 (0.53) | GNAI3GNAO1GNAI1SIGMAR1HRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240122859-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | NOKHA TRADING LLP (IN) | 2024-04-18 | — | — | US | claimed |
| WO-2022172225-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | LYRUS LIFE SCIENCES PVT. LTD. (IN) | 2022-08-18 | — | — | WO | claimed |
| US-20170135347-A1 | INSECTICIDAL, MITICIDAL, NEMATICIDAL, MOLLUSCICIDAL, MICROBICIDAL, OR BACTERICIDAL COMPOSITION AND METHOD FOR CONTROLLING PEST | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-05-18 | — | — | US | claimed |
| CN-106659160-A | Insecticide, miticide, nematicide, molluscicide, disinfectant, or bactericide composition, and pest control method | 日产化学工业株式会社 | 2017-05-10 | — | — | CN | claimed |
| EP-2496089-B1 | AGENT FOR EXPELLING PARASITES IN HUMANS, ANIMALS OR BIRDS | MEIJS MARIA WILHELMINA (BE) | 2017-02-22 | — | — | EP | claimed |
| CN-104125774-A | Pest control composition comprising novel iminopyridine derivatives | MEIJI SEIKA PHARMA CO LTD | 2014-10-29 | — | — | CN | claimed |
| US-20140315839-A1 | PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2014-10-23 | — | — | US | claimed |
| US-8709440-B2 | Agent for expelling parasites in humans, animals or birds | MOMENTUM ANIMAL CURE BVBA (BE) | 2014-04-29 | — | — | US | claimed |
| WO-2013129688-A1 | PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2013-09-06 | — | — | WO | claimed |
| EP-2633756-A1 | Pest control composition including novel iminopyridine derivate | Meiji Seika Pharma Co., Ltd. (JP) | 2013-09-04 | — | — | EP | claimed |
| US-20120231032-A1 | AGENT FOR EXPELLING PARASITES IN HUMANS, ANIMALS OR BIRDS | MEIJS, M.W. (BE) | 2012-09-13 | — | — | US | claimed |
| CN-102325451-A | Composition to control harmful organisms that contains 16-keto aspergillimide | MEIJI SEIKA KAISHA | 2012-01-18 | — | — | CN | claimed |
| US-20110263520-A1 | COMPOSITION FOR USE IN CONTROLLING HARMFUL ORGANISMS THAT CONTAINS 16-KETO ASPERGILLIMIDE | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2011-10-27 | — | — | US | claimed |
| EP-2380439-A1 | COMPOSITION TO CONTROL HARMFUL ORGANISMS THAT CONTAINS 16-KETO ASPERGILLIMIDE | Meiji Seika Pharma Co., Ltd. (JP) | 2011-10-26 | — | — | EP | claimed |
| EP-1599190-A2 | CONTROLLED RELEASE MODIFYING COMPLEX AND PHARMACEUTICAL COMPOSITIONS THEREOF | Glenmark Pharmaceuticals Limited (IN) | 2005-11-30 | — | — | EP | claimed |
| US-20040185097-A1 | Controlled release modifying complex and pharmaceutical compositions thereof | GLENMARK PHARMACEUTICALS LTD. | 2004-09-23 | — | — | US | claimed |
| WO-2004066910-A2 | CONTROLLED RELEASE MODIFYING COMPLEX AND PHARMACEUTICAL COMPOSITIONS THEREOF | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-08-12 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140315839-A1 | PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE | API5, DDT, INTS9 | GNAI3 3164/4885GNAO1 3384/4885GNAI1 2810/4885 |
| US-20110263520-A1 | COMPOSITION FOR USE IN CONTROLLING HARMFUL ORGANISMS THAT CONTAINS 16-KETO ASPERGILLIMIDE | MGAM, CYP51A1, AKR7A2 | GNAI3 3175/4885GNAO1 3489/4885GNAI1 3068/4885 |
| US-20170135347-A1 | INSECTICIDAL, MITICIDAL, NEMATICIDAL, MOLLUSCICIDAL, MICROBICIDAL, OR BACTERICIDAL COMPOSITION AND METHOD FOR CONTROLLING PEST | DDT, ACHE, DRD5 | GNAI3 3896/4885GNAO1 4151/4885GNAI1 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.